Gilead Sciences
S&P 500
Nasdaq 100
$167.47
-1.68%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 9.8 times.
- Return on equity is healthy at 65.3%.
- Return on capital employed is healthy at 25.3%.
- Net profit margin is strong at 28.9%.
- Current assets comfortably cover current liabilities (current ratio 1.55).
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 1.91 is above 1.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Piotroski F-ScoreStrong
7 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$207.72B
Current Price$ 167.47
High / Low$ 175.65 / 116.88
Stock P/E24.70
Book Value$ 10.42
Dividend Yield1.91%
ROCE25.31%
ROE65.26%
Debt to Equity1.91
Current Ratio1.55
P/B Ratio15.937381
EPS$ 6.78
Debt$24.94B
PAT Margin28.90%
Cash PAT$8.88B
ICR9.79